LUPUS NEPHRITIS
Clinical trials for LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lupus kidney drug trial halted Mid-Study
Disease control TerminatedThis study tested an experimental drug, zetomipzomib, in people with active lupus nephritis (kidney inflammation caused by lupus). The goal was to see if the drug could improve kidney function better than a placebo over 52 weeks. The trial was stopped early, and results are not y…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Promising kidney drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called ALXN2050 in 100 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. Participants took the drug or a placebo for up to 50 weeks. The trial was stop…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Kidney disease drug trial stopped early: what we learned
Disease control TerminatedThis study tested a drug called ravulizumab in 123 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. The trial was terminated early, but the results may still help researchers …
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC